FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

T Safra

Research Profile

Chemicals & Drugs

Disorders

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Genes & Molecular Sequences

Physiology

Germ-Line Mutation

Co-author Network

Publications

TOP 3
T Safra; Maria Ornella Nicoletto; Akiva Novetsky; Sharon Pelles-Avraham; Linda Rolnitzky; Lucia Borgato; Leslie Boyd; John Curtin; Martin Edward Donach; Alberto Gabizon; Ravit Geva; Tal Grenader; Wei-Chu V Lai; Franco Muggia
BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin.
T Safra; Susan Groshen; Susan Jeffers; Denice D Tsao-Wei; L Zhou; Laila I Muderspach; Lynda Roman; C Paul Morrow; Alexander Burnett; Franco M Muggia
Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcome.
T Safra; Franco Muggia; Susan Jeffers; Denice D Tsao-Wei; Susan Groshen; Olga Lyass; R Henderson; G Berry; Alberto Gabizon
Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of T Safra (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: T Safra; Maria Ornella Nicoletto; Akiva Novetsky; Sharon Pelles-Avraham; Linda Rolnitzky; Lucia Borgato; Leslie Boyd; John Curtin; Martin Edward Donach; Alberto Gabizon; Ravit Geva; Tal Grenader; Wei-Chu V Lai; Franco Muggia
BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin.
Molecular cancer therapeutics 2011;10(10):2000-7.
2001: T Safra; Susan Groshen; Susan Jeffers; Denice D Tsao-Wei; L Zhou; Laila I Muderspach; Lynda Roman; C Paul Morrow; Alexander Burnett; Franco M Muggia
Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcome.
Cancer 2001;91(1):90-100.
2000: T Safra; Franco Muggia; Susan Jeffers; Denice D Tsao-Wei; Susan Groshen; Olga Lyass; R Henderson; G Berry; Alberto Gabizon
Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):1029-33.
1998: T Safra; Susan Jeffers; Joan Sorich; Franco M Muggia
Gemcitabine plus cisplatin combination given with amifostine (GAP) to heavily pretreated patients with gynecologic and peritoneal cancers: tolerance and activity in ovarian cancer.
Anti-cancer drugs 1998;9(6):511-4.
1997: Franco M Muggia; Susan Jeffers; Laila I Muderspach; Lynda Roman; R Rosales; Susan Groshen; T Safra; C Paul Morrow
Phase I/II study of intraperitoneal floxuridine and platinums (cisplatin and/or carboplatin).
Gynecologic oncology 1997;66(2):290-4.